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Abstract  
 
Purpose of Review: Maintenance of T cell function and modulation of tolerance are critical 
issues in organ transplantation. The thymus is the primary organ for T cell generation, and a 
preserved thymic function is essential for a self-tolerant diverse T cell repertoire. Transplant 
procedures and related immunosuppressive drugs may hinder thymic integrity and function. We 
review here recent advances in understanding the regulation of the unique thymic 
microenvironment with relevance for the field of transplantation. 
Recent findings: Recent studies have assigned a role for IL-22 in the regeneration of thymic 
epithelium, and for micro RNAs in the modulation of its survival and function. The interplay of 
key molecules in the cross-talk between thymic epithelial cells and thymocytes was depicted, 
opening new perspectives for the in vitro recapitulation of T cell development and for thymic 
transplantation. Additionally, the thymus was shown to be able to sustain thymocyte progenitor 
renewal.  
Summary: These findings open new venues of research towards: 1) Therapeutic interventions 
in the endogenous thymus to modulate or reconstitute the immune system; 2) Thymic 
transplantation; and 3) The future development of artificial thymus, which would represent an 
important tool to achieve tolerance across histocompatibility barriers.   
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Introduction 
The thymus is the primary organ for T cell development, where a T cell repertoire able to 
recognize foreign antigens, yet tolerant to self, is generated early in life [1]. The contribution of 
the thymus to T cell homeostasis after the first years of life was neglected for many years due to 
the acknowledged age-dependent thymic involution [2-4]. However, there is now clear data 
supporting life-long thymic activity, posing the thymus as a fundamental target for the 
replenishment of the T cell compartment [5,6]. The thymus is sometimes removed in part or 
whole for cardiac or lung transplantation raising concerns about the life-long impact of 
thymectomy [7-9]. Organ transplantation is usually associated with the use of 
immunosuppressive therapies that hinder the thymus. Residual thymic function and thymic 
regeneration might be key to re-establish host defense [10]. Deliberate thymus manipulation by 
direct or peripheral injection of antigen or cells might be used to generate allogeneic tolerance 
[11]. Finally, the thymus itself is sometimes transplanted, either to establish immunity [12] or to 
generate tolerance [13]. Recent findings set the scene for promising strategies to be used in 
clinical settings of organ transplantation to ensure immune reconstitution upon 
immunosuppressive interventions and/or to modulate T cell tolerance (Figure 1). 
 
Thymus transplantation  
Hematopoietic precursors originated in the bone marrow enter the thymus through the cortico-
medullary junction and must proceed through a series of stages to become mature, functional T 
cells. These stages are characterized by expression of CD4 and CD8, as well as CD3, at the 
surface of thymocytes, with the different stages of T cell development being differentially located 
in the thymus: immature double positive (DP, CD4
+
CD8
+
) cells are found in the cortex, while 
more mature CD4 single positive (CD4SP, CD4
+
CD8
neg
CD3
high
) and CD8 single positive 
(CD8SP, CD4
neg
CD8
+
CD3
high
) are located in the medulla [14]. 
Thymocyte differentiation is dependent on the interaction of developing thymocytes with other 
cells, particularly thymic epithelial cells (TEC) and dendritic cells (DC), in order to ensure that 
the T cells produced are able to recognize self-MHC (positive selection, mainly mediated by 
cortical TECs) but do not become activated upon self-antigen presentation (negative selection, 
mediated by DCs and medullary TEC) [15,16]. 
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Defects in thymic development, like DiGeorge syndrome, or mutations in genes essential for 
TEC differentiation, such as Forkhead box N1 (FOXN1), may result in athymia, defined by less 
than 1% naïve T cells in the blood [17,18]. These cases of severe immunodeficiency can only 
be treated with thymus transplantation. Thymic transplantation, previously applied in the 
treatment of complete DiGeorge anomaly in infancy [12,19], has been successfully used for the 
first time in the context of another clinical setting characterized by putative athymia, FOXN1 
deficiency [20,21*]. Importantly, functional immune-competence was obtained using an HLA-
mismatched thymus, and was sustained despite evidence of allograft involution 3 years post 
thymus transplantation [21*]. These findings suggest that a transitory period of thymic activity is 
sufficient to ensure the establishment of a functional imune system. Furthermore, they provide 
new insights for the design of immunological reconstitution strategies based on thymic 
transplantation, including xenotransplantation [22]. Additionally, the potential of the conjoint use 
of thymus transplantation with hematopoietic stem-cell transplantation (HSCT) to facilitate long-
term immune reconstitution in the context of severe combined immunodeficiencies (SCID) is 
also an area of research [23].   
 
Manipulation of thymic activity in the context of solid organ transplantation 
There is increasing evidence supporting that a normal thymus is able to export mature T cells 
throughout life, although with a progressive decline with age [5,6]. Nevertheless, the current 
tools available to accurately estimate the diversity and function of the T cells that emigrate from 
the thymus are limited. Furthermore, the mechanisms underlying thymic changes throughout 
life, including the relative contribution of putative impairments of precursor cells and of the 
thymic microenvironment, remain unclear. The progressive decline of thymic function with age is 
considered an important factor in limiting the success of bone marrow transplantation in the 
elderly [24,25]. Strategies to recover thymic function and to ensure the replenishment of the 
peripheral compartment with a pool of newly generated diverse T cells are particularly crucial in 
situations that may lead to T cell depletion, such as immunosuppressive therapies, 
radiation/chemotherapy and HIV infection. The thymic epithelium is particularly susceptible to 
the deleterious effects of stress, inflammation, infections and immunosuppressive drugs, 
leading to impaired thymopoiesis [26]. Understanding the mechanisms underlying the 
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preservation and recovery of the thymic microenvironment is of paramount importance for its 
therapeutic targeting. 
 
IL-22 as a novel player in thymic epithelium recovery 
Interleukin 22 (IL-22) has been suggested to have a fundamental role in tissue homeostasis and 
repair [27]. It is produced by subsets of CD4 T cells and of innate lymphoid cells (ILC) and 
mainly targets epithelial cells. IL-22 was recently identified as an important player in thymic 
regeneration [28**,29]. Dudakov et al. found that IL-22-deficient mice presented impaired thymic 
regeneration upon sublethal total body irradiation and were unable to reconstitute thymic 
cellularity upon subsequent hematopoietic stem cell transplantation. Moreover, IL-22 production 
increased upon thymic insult in wild type mice. IL-22 appeared to be mainly produced by thymic 
ILCs in response to tissue damage, and this process was at least partly regulated by DCs 
through the production of IL-23. The receptor for IL-22 was shown to be expressed on TECs 
and to induce their survival and proliferation. This direct impact of IL-22 on TECs may have 
many potential applications. 
 
Fine-tuning of thymic epithelium function by micro RNAs  
Thymic involution is mediated by a variety of factors such as sex hormones, physiological 
stress, inflammation and infection, but the mechanisms underlying the action of each factor are 
not completely understood. Recently, micro RNAs (miRNAs) have been found to be essential in 
maintaining the competence of the thymic epithelia in the mouse [30**,31**]. This class of small 
noncoding RNAs controls the cellular RNA machinery by targeting and down-regulating the 
expression of mRNAs [32]. Dicer is an RNAse III critical for miRNA generation by catalyzing 
miRNA duplex formation [33]. Papadopoulou et al. have found that thymic epithelial cell-specific 
deletion of Dicer resulted in the degeneration of thymic architecture and function, inducing 
heightened sensitivity to involution signals [30**]. Furthermore, targeted deletion of the miR-29a 
cluster recapitulated premature thymic involution and hypersensitivity to pathogen-associated 
signals found in the absence of Dicer, revealing this particular miRNA family as a key modulator 
of the threshold of thymic epithelium responses to pathogens. 
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In another study, Zuklys et al. also found that T cells generated in a miRNA-free TEC 
environment elicited autoimmunity, possibly due to the reduction of the expression of self-
antigens in medullary TECs, leading to an impaired control of auto-reactive T cells in the thymus 
[31**]. 
Overall, a major role for miRNAs in thymic epithelium function and maintenance was revealed, 
raising new perspectives for therapeutic intervention. 
 
Identifying the molecular requirements for the cross-talk between TECs and thymocytes  
The identification of the requirements for T cell commitment and development has been the 
subject of extensive research. Caldéron and Boehm have recently revealed a hierarchy of 
molecular cues that governs the differentiation of hematopoietic progenitors in the murine 
thymus enlagen [34**,35]. In their model, the chemokines Ccl25 and Cxcl12, the cytokine stem-
cell factor (Scf) and the Notch ligand delta-like 4 (DLL4), not expressed in Foxn1-deficient 
epithelia, were placed under the regulation of the Foxn1 promoter in Foxn1-deficient mice. 
Foxn1 is a transcription factor crucial for thymic epithelium development and prevention of its 
involution [36,37]. While the expression of Ccl5, Cxcl12 or Scf was sufficient for hematopoietic 
progenitor cells to be detectable, although at very low levels, DLL4 alone did not induce 
hematopoietic activity. However, through the combinatorial expression of the four molecules the 
authors uncovered determinants of the microenvironmental niche required for T cell 
development. According to their results, Ccl25 was positioned at the bottom of the functional 
hierarchy, while DLL4 had a dominant T cell promoting function over the other molecules 
studied. In the absence of Notch function, Cxcl12 was found to promote B cell development, 
while Scf appeared to generate a favorable environment for mast cell progenitors. Importantly, 
the combined expression of Cxcl12 and DLL4 in Foxn1-deficient epithelia was sufficient to 
support T cell development up to the DP stage, probably due to the chemotactic activity of 
Cxcl12, lacked by DLL4.  Moreover, these DP T cells were able to differentiate into mature 
CD4SP and CD8SP cells in the presence of wild-type thymic epithelium in reaggregate thymus 
organ culture, suggesting that interruption of thymopoiesis at that stage was due to the lack of 
critical extracellular signals in Foxn1-deficient epithelia.  
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These results are of paramount importance for the manipulation of hematopoietic progenitor 
niches, with potential clinical applications.   
 
The human phenotype of FOXN1 deficiency and its recovery by thymic transplantation 
We and others have shown that children with a homozygous FOXN1 mutation (R255X) feature 
T cells of non-maternal origin, despite the athymia [18,20,21*]. The circulating T cells present an 
activated memory-like phenotype, impaired function and an oligoclonal repertoire, with an 
aberrant over-representation of CD4
neg
CD8
neg
 double negative and of Forkhead box P3 
(FOXP3) regulatory-like αβ T cells [21*]. Several possibilities may be raised to explain their 
origin. A thymic origin of circulating T cells in human FOXN1 deficiency cannot be excluded. It is 
plausible that the FOXN1 mutation allowed the development of a thymic rudiment able to 
support altered thymopoiesis, with possible disturbances in positive/negative selection, as 
suggested by the double negative and FOXP3+ cell expansions. On the other hand, an 
extrathymic origin should also be considered, although the possibility of T cell development in 
lymph nodes and/or gut has been subject of intense debate and controversial data [38,39]. In 
this respect, two recent reports should be considered, which describe the potential of human 
tonsils to support T cell development [40*] and the possible contribution of mesenteric lymph 
nodes for extrathymic development of murine T cells upon administration of bone marrow 
progenitors [41*].  
 
Revealing the thymic ability to sustain thymopoiesis in the absence of progenitor input 
It was long believed that the thymus was entirely dependent on the inner traffic of progenitor 
cells from the bone marrow. This notion derived from the observation that transplantation of wild 
type thymus grafts into T cell deficient mice resulted in the export of a single wave of graft-
derived T cells, and that colonization of the graft by developmentally impaired progenitors from 
the bone marrow resulted in cessation of T cell production [42,43]. Peaudecerf et al. [44**] and 
Martins et al. [45**] revisited this dogma, showing in mouse models that the thymus harbors 
progenitors with self-renewal potential that are able to maintain T cell development in the 
absence of competition from bone marrow progenitors. These recent studies unveil a 
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mechanism of regulation of normal thymocyte development by niche occupancy and 
competitive progenitor replacement. 
Overall, these studies highlight the capacity of the thymus to support cells with long-term 
renewal potential.  
 
Intrathymic injection of thymocyte progenitors 
The intrathymic delivery of thymocyte progenitors has been investigated as a strategy to reduce 
the delay in immune reconstitution following hematopoietic stem cell transplantation, a main 
cause of the associated morbidity and mortality. Recent studies from de Barros et al. in murine 
models showed that, in the absence of of myeloablative conditioning, the forced thymic entry of 
semiallogeneic progenitors results in sustained T cell development, even across 
histocompatibility barriers [46*].  
 
Modulating T cell responses at the thymic level  
Another important area of thymic intervention relates to the role of the thymus in the 
establishment of the T cell receptor repertoire. Much effort has been devoted into developing 
ways to achieve hematopoietic chimerism for the purpose of generating central tolerance [11]. 
Moreover, the development of strategies to induce tolerance through the direct introduction of 
antigens in the thymus has been a long pursued goal in the field of transplantation [47,48]. 
Several approaches have been attempted to modulate specific T cell responses, including the 
intrathymic injection of antigens using lentiviral vectors as recently reported by Gottrand et al. 
[49*].  On the other hand, although the thymus is generally considered an immune-privileged 
organ, increasing evidence points to a recirculation of mature T cells and antigen-presenting 
cells through the thymus, with possible modulation of peripheral effector and regulatory T cell 
responses [50]. The majority of the studies addressing this issue have been conducted in 
mouse models of infection, such as the recently published work of Nobrega et al. with 
Mycobacteria [51*]. This field of research has an immense translational potential in the context 
of organ transplantation to induce tolerance. In this regard, we have recently identified the DP 
stage of thymocyte development as a potential target for the modulation of thymic-derived 
FOXP3
+
 regulatory T cells [52*]. These findings illustrate an early generation of this important 
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subset for T cell homeostasis and self-tolerance, with critical implications for the diversity and 
autoreactivity of the natural Treg-cell repertoire.   
 
Conclusions 
The thymus has recently emerged as a promissory target for therapeutic intervention in the field 
of organ transplantation. Its unique regenerative potential and the identification of new key 
pathways involved raise prospects to modulate or rebuild the patient’s immune system. These 
advances in the comprehension of the thymic microenvironment regulation will be instrumental 
for therapeutic interventions in the endogenous thymus, thymic transplantation, and future 
development of artificial thymus, which would represent an important tool to achieve tolerance 
across histocompatibility barriers.   
 
Key Points: 
1. The central role of the thymus in the establishment of the T cell receptor repertoire and 
tolerance disclose a potential in organ transplantation that is beginning to be explored. 
2. IL-22 was recently revealed as a major pathway underlying the unique ability of the 
thymus to regenerate. 
3. Critical molecular mechanisms that regulate the function of the thymic epithelia were 
uncovered, which may translate into advances in the modulation of the thymic 
microenvironment, as well as in the generation of a putative artificial thymus.  
4. The thymus was shown to have the ability to sustain thymocyte progenitor renewal. 
5. The human phenotype of FOXN1 deficiency, a key molecule for thymic epithelium 
development and function, and its recovery upon thymic transplantation was 
comprehensively characterized.   
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Figure Legend 
 
Figure 1: Overview of T cell development in the thymus and recent studies that bring new 
light to the modulation and boost of thymic function. (DN: double negative, DP: double 
positive, SP: single positive, cTEC: cortical thymic epithelial cell, mTEC: medullary thymic 
epithelial cell, DC: dendritic cell). 
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